Myriad Genetics Dl 01 Aktie - MYD

Professionelle Tools für Privatanleger.

Premium

Current Price

9,55

Gebot

9,45

Fragen

9,60

Volumen

6.158

9,40 Tagesbereich 10,20

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

869,386M

Handelsende

9,35

Handelsbeginn

9,40

Letzte Trade

100

9.65

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

91.035.230

Dividendenrendite

Kurs-Gewinn-Verhältnis

-3,60

Gewinn pro Aktie (EPS)

-2,89

Erlöse

753,2M

Nettogewinn

-263,3M

Sektor

In Vitro,in Vivo Diagnostics

Branche

In Vitro,in Vivo Diagnostics

Website

www.myriad.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Myriad Genetics Dl 01 is listed in the In Vitro,in Vivo Diagnostics sector of the Tradegate (DE) with ticker MYD. The last closing price for Myriad Genetics Dl 01 was 9,35 €. Over the last year, Myriad Genetics Dl 01 shares have traded in a share price range of 0,00 € to 0,00 €.

Myriad Genetics Dl 01 currently has 91.035.230 shares in issue. The market capitalisation of Myriad Genetics Dl 01 is 851,18 € million. Myriad Genetics Dl 01 has a price to earnings ratio (PE ratio) of -3.60.

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries New sponsored testing program leverages Myriad’s...

Novo estudo publicado no Clinical Cancer Research Journal destaca o uso do teste EndoPredict para informar o tratamento em pacientes com câncer de mama na pré-menopausa

Novo estudo publicado no Clinical Cancer Research Journal destaca o uso do teste EndoPredict para informar o tratamento em pacientes com câncer...

Myriad Genetics s'associe à l'Institut für Hämopathologie Hamburg et au Centre Georges-François Leclerc pour étendre l'accès aux tests génétiques en Europe

Myriad Genetics s'associe à l'Institut für Hämopathologie Hamburg et au Centre Georges-François Leclerc pour étendre l'accès aux...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

MYD - Frequently Asked Questions (FAQ)

What is the current Myriad Genetics Dl 01 share price?

The current share price of Myriad Genetics Dl 01 is 9,55 €

How many Myriad Genetics Dl 01 shares are in issue?

Myriad Genetics Dl 01 has 91.035.230 shares in issue

What is the market cap of Myriad Genetics Dl 01?

The market capitalisation of Myriad Genetics Dl 01 is EUR 851,18M

What is the 1 year trading range for Myriad Genetics Dl 01 share price?

Myriad Genetics Dl 01 has traded in the range of 0,00 € to 0,00 € during the past year

What is the PE ratio of Myriad Genetics Dl 01?

The price to earnings ratio of Myriad Genetics Dl 01 is -3,6

What is the cash to sales ratio of Myriad Genetics Dl 01?

The cash to sales ratio of Myriad Genetics Dl 01 is 1,26

What is the reporting currency for Myriad Genetics Dl 01?

Myriad Genetics Dl 01 reports financial results in USD

What is the latest annual turnover for Myriad Genetics Dl 01?

The latest annual turnover of Myriad Genetics Dl 01 is USD 753,2M

What is the latest annual profit for Myriad Genetics Dl 01?

The latest annual profit of Myriad Genetics Dl 01 is USD -263,3M

What is the registered address of Myriad Genetics Dl 01?

The registered address for Myriad Genetics Dl 01 is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Myriad Genetics Dl 01 website address?

The website address for Myriad Genetics Dl 01 is www.myriad.com

Which industry sector does Myriad Genetics Dl 01 operate in?

Myriad Genetics Dl 01 operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
DP8CervoMed Inc	6,25 € (192,06%)	123,89k
49QZenatech Inc	4,86 € (86,92%)	3,67k
M0YNMynaric AG	1,305 € (79,26%)	1,26M
7IPImpro Precision Industries Limited	0,478 € (61,49%)	750
D7GNel ASA	0,3199 € (61,16%)	66,72M
WIG1Wige Media AG	0,034 € (-64,77%)	1,49M
GTYGateway Real Estate AG	0,30 € (-42,31%)	30,37k
I8RIrobot Corp Dl 01	3,735 € (-35,87%)	116,47k
0S90Syros Pharmaceuticals Inc	0,0715 € (-32,55%)	68,93k
NL8Genesis Ai Corp	0,01 € (-31,51%)	205,46k
D7GNel ASA	0,3199 € (61,16%)	66,72M
UH7ATennant Minerals NL	0,0075 € (-16,67%)	3,6M
3CPXiaomi Corporation	6,20 € (-3,28%)	1,72M
TKAThyssenkrupp AG	8,71 € (2,16%)	1,71M
PUMPuma SE	22,68 € (-14,09%)	1,68M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Myriad Genetics Dl 01 (MYD)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Myriad Genetics Dl 01

MYD Neueste Nachrichten

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

Novo estudo publicado no Clinical Cancer Research Journal destaca o uso do teste EndoPredict para informar o tratamento em pacientes com câncer de mama na pré-menopausa

Myriad Genetics s'associe à l'Institut für Hämopathologie Hamburg et au Centre Georges-François Leclerc pour étendre l'accès aux tests génétiques en Europe

MYD - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Myriad Genetics Dl 01 (MYD) Börsenkurse

Myriad Genetics Dl 01 (MYD)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Myriad Genetics Dl 01

MYD Neueste Nachrichten

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

Novo estudo publicado no Clinical Cancer Research Journal destaca o uso do teste EndoPredict para informar o tratamento em pacientes com câncer de mama na pré-menopausa

Myriad Genetics s'associe à l'Institut für Hämopathologie Hamburg et au Centre Georges-François Leclerc pour étendre l'accès aux tests génétiques en Europe

MYD - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE